Some NIH study sections will resume reviewing grants, but final funding decisions are still in limbo
While some NIH study sections will resume, advisory council meetings, which make final funding decisions, seem to still be ...
Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback